Technical Analysis for VERU - Veru Inc.

Grade Last Price % Change Price Change
grade C 1.59 4.61% 0.07
VERU closed up 4.61 percent on Thursday, March 21, 2019, on 1.54 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical VERU trend table...

Date Alert Name Type % Chg
Mar 21 Upper Bollinger Band Walk Strength 0.00%
Mar 21 Upper Bollinger Band Touch Strength 0.00%
Mar 20 Upper Bollinger Band Walk Strength 4.61%
Mar 20 Inside Day Range Contraction 4.61%
Mar 20 Upper Bollinger Band Touch Strength 4.61%
Mar 19 200 DMA Resistance Bearish 1.92%
Mar 19 Expansion Pivot Buy Setup Bullish Swing Setup 1.92%
Mar 19 Pocket Pivot Bullish Swing Setup 1.92%
Mar 19 Volume Surge Other 1.92%
Mar 19 Wide Range Bar Range Expansion 1.92%

Older signals for VERU ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Veru Inc., a medical therapeutics company, develops, manufactures, and markets consumer health care products. The company’s pharmaceuticals product portfolio includes Tamsulosin delayed release sachet that is under bioequivalence study for the treatment of benign prostatic hyperplasia; MSS-722, a fixed ratio of trans- and cis-clomiphene citrate isomers, which is under the Phase II clinical trial to treat male infertility caused by testicular dysfunction; APP-944, a zuclomiphene citrate that is under the Phase II clinical trial for the treatment of hot flashes in men on prostate cancer hormonal therapies; and APP-111, an oral tubulin targeting chemotherapy, which is under the preclinical study to treat metastatic prostate, breast, and ovarian cancers, as well as APP-111/112 oral agents that target colchicine binding site of tubulin for the treatment of gout and familial mediterranean fever. It also provides consumer health and medical devices, including PREBOOST benzocaine wipes for premature ejaculation; and FC2, which is female disposable contraceptive device, as well as FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV/AIDS and the Zika virus. The company primarily serves global agencies, non-government organizations, ministries of health, and other governmental agencies directly, as well as through distribution agreements and other arrangements with commercial partners. It has operations in the United States, Brazil, Zimbabwe, South Africa, Angola, the Democratic Republic of the Congo, Tanzania, Malaysia, Spain, France, the United Kingdom, and internationally. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was founded in 1896 and is headquartered in Miami, Florida.
Chemistry Pharmaceuticals Chemical Compounds Organic Compounds Chemotherapy Prostate Cancer Infections Hiv/Aids Benign Prostatic Hyperplasia Gout Consumer Health Care Products Male Infertility Ovarian Cancers Treatment Of Benign Prostatic Hyperplasia
Is VERU a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.37
52 Week Low 1.18
Average Volume 146,693
200-Day Moving Average 1.6461
50-Day Moving Average 1.4261
20-Day Moving Average 1.4315
10-Day Moving Average 1.471
Average True Range 0.1062
ADX 17.4
+DI 27.099
-DI 11.6119
Chandelier Exit (Long, 3 ATRs ) 1.3814
Chandelier Exit (Short, 3 ATRs ) 1.4986
Upper Bollinger Band 1.6169
Lower Bollinger Band 1.2461
Percent B (%b) 0.93
BandWidth 25.902899
MACD Line 0.0327
MACD Signal Line 0.0159
MACD Histogram 0.0168
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.77
Resistance 3 (R3) 1.77 1.70 1.74
Resistance 2 (R2) 1.70 1.66 1.70 1.73
Resistance 1 (R1) 1.65 1.63 1.67 1.65 1.72
Pivot Point 1.58 1.58 1.60 1.58 1.58
Support 1 (S1) 1.53 1.54 1.56 1.53 1.46
Support 2 (S2) 1.46 1.51 1.47 1.45
Support 3 (S3) 1.41 1.46 1.44
Support 4 (S4) 1.41